Northern Trust’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-572,845
Closed -$86.6M 4800
2022
Q3
$86.6M Sell
572,845
-1,925
-0.3% -$291K 0.02% 594
2022
Q2
$83.7M Buy
574,770
+48,218
+9% +$7.03M 0.02% 622
2022
Q1
$62.4M Sell
526,552
-54,922
-9% -$6.51M 0.01% 881
2021
Q4
$80.1M Buy
581,474
+25,281
+5% +$3.48M 0.01% 778
2021
Q3
$77.3M Sell
556,193
-3,672
-0.7% -$510K 0.01% 795
2021
Q2
$54.4M Buy
559,865
+19,323
+4% +$1.88M 0.01% 1066
2021
Q1
$36.9M Sell
540,542
-18,432
-3% -$1.26M 0.01% 1361
2020
Q4
$47.9M Sell
558,974
-12,145
-2% -$1.04M 0.01% 1107
2020
Q3
$37.1M Sell
571,119
-15,497
-3% -$1.01M 0.01% 1119
2020
Q2
$42.9M Buy
586,616
+61,824
+12% +$4.52M 0.01% 1006
2020
Q1
$17.9M Buy
524,792
+49,949
+11% +$1.7M 0.01% 1485
2019
Q4
$25.9M Sell
474,843
-15,006
-3% -$817K 0.01% 1525
2019
Q3
$20.4M Buy
489,849
+91,128
+23% +$3.8M ﹤0.01% 1679
2019
Q2
$17.5M Buy
398,721
+13,613
+4% +$596K ﹤0.01% 1782
2019
Q1
$19.8M Buy
385,108
+39,475
+11% +$2.03M ﹤0.01% 1698
2018
Q4
$12.8M Sell
345,633
-636
-0.2% -$23.5K ﹤0.01% 1904
2018
Q3
$13M Buy
346,269
+22,346
+7% +$839K ﹤0.01% 2093
2018
Q2
$12.8M Buy
323,923
+20,093
+7% +$794K ﹤0.01% 2105
2018
Q1
$7.83M Buy
303,830
+186,274
+158% +$4.8M ﹤0.01% 2326
2017
Q4
$3.17M Buy
117,556
+148
+0.1% +$3.99K ﹤0.01% 2872
2017
Q3
$4.39M Buy
117,408
+4,381
+4% +$164K ﹤0.01% 2706
2017
Q2
$2.83M Buy
+113,027
New +$2.83M ﹤0.01% 2953